Dr. Pan Pan has over 10 years of experience in Strategic Planning, Business Development & Licensing, Alliance Management, and Drug Development. He has been focused on collaborative development, strategic partnering and licensing transactions for innovative biological drugs in oncology and immunology. Dr. Pan has served as the group lead of Business Development at Akeso Biopharam, KLUS Pharma, and several other small to mid-cap biotech companies, with a track record of executing partnerships with record-high values, including a $1.4B license to Merck & Co. and a $5B license to Summit Therapeutics. Prior to his Business Development career, Dr. Pan led protein engineering at Arkema Inc and received several patent grants. Dr. Pan received his PhD in Chemistry from Stony Brook University and an MBA from University of Massachusetts Amherst.
